232 related articles for article (PubMed ID: 29678543)
1. Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features.
Munir MU; Ihsan A; Sarwar Y; Bajwa SZ; Bano K; Tehseen B; Zeb N; Hussain I; Ansari MT; Saeed M; Li J; Iqbal MZ; Wu A; Khan WS
Int J Pharm; 2018 Jun; 544(1):112-120. PubMed ID: 29678543
[TBL] [Abstract][Full Text] [Related]
2. Hollow mesoporous hydroxyapatite nanoparticles (hmHANPs) with enhanced drug loading and pH-responsive release properties for intracellular drug delivery.
Yang YH; Liu CH; Liang YH; Lin FH; Wu KC
J Mater Chem B; 2013 May; 1(19):2447-2450. PubMed ID: 32261043
[TBL] [Abstract][Full Text] [Related]
3. Dual functioning microspheres embedded crosslinked gelatin cryogels for therapeutic intervention in osteomyelitis and associated bone loss.
Pandey G; Mittapelly N; Pant A; Sharma S; Singh P; Banala VT; Trivedi R; Shukla PK; Mishra PR
Eur J Pharm Sci; 2016 Aug; 91():105-13. PubMed ID: 27287423
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus.
Maleki Dizaj S; Lotfipour F; Barzegar-Jalali M; Zarrintan MH; Adibkia K
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):535-543. PubMed ID: 27012878
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity.
Ciocilteu MV; Mocanu AG; Mocanu A; Ducu C; Nicolaescu OE; Manda VC; Turcu-Stiolica A; Nicolicescu C; Melinte R; Balasoiu M; Croitoru O; Neamtu J
Acta Pharm; 2018 Jun; 68(2):129-144. PubMed ID: 29702474
[TBL] [Abstract][Full Text] [Related]
6. Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations.
Placente D; Benedini LA; Baldini M; Laiuppa JA; Santillán GE; Messina PV
Int J Pharm; 2018 Sep; 548(1):559-570. PubMed ID: 30016671
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
Krishnan AG; Jayaram L; Biswas R; Nair M
Tissue Eng Part A; 2015 Apr; 21(7-8):1422-31. PubMed ID: 25567452
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyapatite grafted chitosan/laponite RD hydrogel: Evaluation of the encapsulation capacity, pH-responsivity, and controlled release behavior.
Heragh BK; Javanshir S; Mahdavinia GR; Jamal MRN
Int J Biol Macromol; 2021 Nov; 190():351-359. PubMed ID: 34492248
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
[TBL] [Abstract][Full Text] [Related]
10. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of pH-sensitive nanocarrier based chitosan-g-poly(itaconic acid) for ciprofloxacin delivery for anti-bacterial application.
Kumar B; Kumar P
Int J Biol Macromol; 2024 May; 268(Pt 2):131604. PubMed ID: 38641270
[TBL] [Abstract][Full Text] [Related]
12. Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
Hanafy AF; Ali HSM; El Achy SN; Habib EE
Drug Dev Ind Pharm; 2018 Jun; 44(6):1023-1033. PubMed ID: 29484904
[TBL] [Abstract][Full Text] [Related]
13. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
14. Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis.
Saidykhan L; Abu Bakar MZ; Rukayadi Y; Kura AU; Latifah SY
Int J Nanomedicine; 2016; 11():661-73. PubMed ID: 26929622
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of sustained ciprofloxacin release from κ-carrageenan-crosslinked chitosan/hydroxyapatite hydrogel nanocomposites.
Mahdavinia GR; Karimi MH; Soltaniniya M; Massoumi B
Int J Biol Macromol; 2019 Apr; 126():443-453. PubMed ID: 30594616
[TBL] [Abstract][Full Text] [Related]
16. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
Mai Z; Chen J; Hu Y; Liu F; Fu B; Zhang H; Dong X; Huang W; Zhou W
J Colloid Interface Sci; 2017 Dec; 508():184-195. PubMed ID: 28841476
[TBL] [Abstract][Full Text] [Related]
17. An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies.
Andrade GF; Gomide VS; da Silva Júnior AC; Goes AM; de Sousa EM
J Mater Sci Mater Med; 2014 Nov; 25(11):2527-40. PubMed ID: 25056197
[TBL] [Abstract][Full Text] [Related]
18. pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles.
Manatunga DC; de Silva RM; de Silva KMN; de Silva N; Bhandari S; Yap YK; Costha NP
Eur J Pharm Biopharm; 2017 Aug; 117():29-38. PubMed ID: 28330763
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
20. Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.
Kundu B; Soundrapandian C; Nandi SK; Mukherjee P; Dandapat N; Roy S; Datta BK; Mandal TK; Basu D; Bhattacharya RN
Pharm Res; 2010 Aug; 27(8):1659-76. PubMed ID: 20464462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
